Anemia in Chronic Heart Failure. Should We Treat It and How?**Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.

Journal of the American College of Cardiology

Volumn 49, Issue 7, 2007, Pages 763-764

  Komajda, Michel ^a  

^a SORBONNE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; PLACEBO;

ANEMIA; CLINICAL TRIAL; COMORBIDITY; DISEASE ASSOCIATION; EDITORIAL; HEART FAILURE; HEMATOCRIT; HOSPITAL ADMISSION; HUMAN; IRON THERAPY; MORTALITY; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE;

ANEMIA; ERYTHROPOIETIN; HEART FAILURE, CONGESTIVE; HEMATINICS; HEMOGLOBINS; HUMANS; INJECTIONS, SUBCUTANEOUS;

EID: 33846923640     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2006.11.023     Document Type: Editorial

References (11)

1. Ezekowitz J.A., McAlister F.A., and Armstrong P.W. Anemia is common in heart failure and is associated with poor outcomes. Circulation 107 (2003) 223-225
2. Al-Ahmad A., Rand W.M., Manjunath G., Konstam M.A., et al. Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction. J Am Coll Cardiol 38 (2001) 955-962
3. Horwich T.B., Fonarrow G.C., Hamilton M.A., MacLellan W.R., et al. Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. J Am Coll Cardiol 39 (2002) 1780-1786
4. Kalra P.R., Bolger A.P., Francis D.P., Gentz-Zotz, et al. Effect of anaemia on exercise tolerance in chronic heart failure in men. Am J Cardiol 91 (2003) 888-891
5. Komajda M., Anker S.D., Charlesworth A., Okonko D., et al. The impact of new onset anaemia on morbidity and mortality in chronic heart failure: results from COMET. Eur Heart J 27 (2006) 1440-1446
6. Anand I.S., Kuskowksi M.A., Rector T.S., Florea V.G., et al. Anemia and change in haemoglobin over time related to mortality and morbidity in patients with chronic heart failure. Results from Val-HeFT. Circulation 112 (2005) 1121-1127
7. Okonko D.O., and Anker S. Anemia in chronic heart failure: pathogenetic mechanisms. J Cardiac Failure 10 Suppl (2004) S5-S9
8. Ishani A., Weinhandl E., Zhao Z., et al. Angiotensin-converting enzyme inhibitor as a risk factor for the development of anemia, and the impact of incident anemia on mortality in patients with left ventricular dysfunction. J Am Coll Cardiol 45 (2005) 391-399
9. Ponikowski P., Anker S.D., and Szachniewicz J. Effect of darbepoetin alfa on exercise tolerance in anemic patients with symptomatic chronic heart failure: a randomized, double-blind, placebo-controlled trial. J Am Coll Cardiol 49 (2007) 753-762
10. Mancini D.M., Katz S.D., Lang C.C., La Manca J., et al. Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure. Circulation 107 (2003) 294-299
11. Silverberg D.S., Wexler D., Sheps D., et al. The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study. J Am Coll Cardiol 37 (2001) 1775-1780